Stifel analyst Daniel Arias lowered the firm’s price target on Illumina (ILMN) to $135 from $160 and keeps a Buy rating on the shares. Illumina posted a “nice” Q1 beat and then reduced the FY25 guidance, as expected, the analyst tells investors. The cut to the top-line “was maybe a point or so deeper than we thought it might be,” but the EPS outlook is better than the firm anticipated thanks to strong mitigation activities, the analyst added.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina price target raised to $89 from $86 at TD Cowen
- Illumina price target lowered to $85 from $120 at JPMorgan
- Illumina price target lowered to $114 from $122 at Guggenheim
- Illumina’s Financial Outlook: Hold Rating Amidst Export Bans and Tariff Challenges
- Illumina Reports Q1 2025 Financial Results Amid Challenges